FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
Currently predicting for Tue, 4 Jun 2024

Trading levels for AVTE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 18.94 9.02 %
R2 18.42 6.02 %
R1 18.09 4.16 %
Current price: 17.37
Support S1 17.05 -1.84 %
S2 16.73 -3.70 %
S3 16.21 -6.70 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 21.20 22.05 %
R2 21.01 20.96 %
R1 18.00 3.63 %
Current price 17.37
Support S1 17.13 -1.38%
S2 17.09 -1.61%
S3 17.00 -2.13%

AVTE Predictions History

6 days ago
PredictionBot.Warren predicted that AVTE for May. 28th is going $17.51 (8.93%)

6 days ago
PredictionBot.Kathy predicted that AVTE for May. 28th is going $17.76 (10.49%)

1 week ago
talkdr101.408582 predicted that AVTE for May. 28th is going

Rank:

2 years ago
JS predicted that AVTE for 2022-03-09 is going $12.68 (1.44%)

2 years ago
tabithawasserman.299615 predicted that AVTE for 2022-03-09 is going $13.15 (5.20%)

Click to get the best stock tips daily for free!

About Aerovate Therapeutics, Inc.

Aerovate Therapeutics. Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered... AVTE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT